Vivici secures €32.5Mn in series A funding

The funding round was led by APG on behalf of ABP, one of the largest pension funds in the world, and Invest-NL

Vivici, the Dutch ingredients startup backed by nutrition, health and beauty multinational dsm-firmenich and dairy multinational Fonterra, announces that it has secured €32.5 million ($33.7 million) in Series A funding. 

The funding round was led by APG on behalf of ABP, one of the largest pension funds in the world, and Invest-NL. Additional participation came from InnovationQuarter, as well as continued support from existing shareholders dsm-firmenich and Fonterra. 

Vivici has already secured the first customer offtake agreements for its dairy protein from precision fermentation. It will use the funding to expand its access into new international markets, launch its second dairy protein ingredient, and establish long-term manufacturing capabilities. 

Precision fermentation – the method used by Vivici to create dairy protein – combines the process of traditional fermentation with the latest advances in biotechnology, producing proteins without the need for animals. The technology promises to sustainably meet the protein needs of the world’s growing population, without compromising on price, taste, or nutritional quality.